Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ACET > SEC Filings for ACET > Form 8-K/A on 10-Jul-2014All Recent SEC Filings

Show all filings for ACETO CORP

Form 8-K/A for ACETO CORP


10-Jul-2014

Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibit


Item 2.01. Completion of Acquisition or Disposition of Assets.

On April 30, 2014, Rising Pharmaceuticals, Inc., a wholly owned subsidiary of Aceto Corporation ("Aceto"), acquired 100% of the issued and outstanding membership interests of PACK Pharmaceuticals, LLC ("PACK"). PACK, a national marketer and distributor of generic prescription and over-the-counter pharmaceutical products, has headquarters in Buffalo Grove, Illinois, a suburb of Chicago. The purchase price was approximately $91,596,000 which was comprised of the issuance of 259,814 shares of Aceto common stock, valued at $5,685,000 and a cash payment of approximately $85,911,000. The purchase agreement also provides for a three-year earn-out of up to $15,000,000 in cash based on the achievement of certain performance-based targets.

On May 2, 2014, Aceto Corporation filed a Current Report on Form 8-K stating that it completed the acquisition of 100% of the membership interests of PACK and that the financial statements and pro forma financial information required under Item 9.01 of Form 8-K would be filed within the time period specified in the instructions to Item 9.01 of Form 8-K. This amended Current Report on Form 8-K contains the required financial statements and pro forma financial information.



Item 9.01. Financial Statements and Exhibits.

(a) Financial Statements of Business Acquired.

The audited financial statements of PACK Pharmaceuticals, LLC, for the fiscal year ended December 31, 2013 are attached hereto as Exhibit 99.1.

(b) Pro Forma Financial Information.

The unaudited pro forma financial information for Aceto, after giving effect to the acquisition of 100% of the membership interests of PACK and adjustments described in such pro forma financial information, are attached hereto as Exhibit 99.2.

Exhibit No. Description

23.1 Consent of Plante & Moran, PLLC.

99.1 Audited financial statements of PACK Pharmaceuticals, LLC for the fiscal year ended December 31, 2013.

99.2     Unaudited pro forma financial information for Aceto, after giving
         effect to the acquisition of 100% of the membership interests of PACK
         and adjustments described in such pro forma financial information.

  Add ACET to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ACET - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.